Answers are grounded in this paper and cite their sources.
Reports m1A dynamics associated with microglial changes and neuronal adaptation in spinal cord injury, suggesting new therapeutic targets.
m 1 A (N1-methyladenosine) is an important epigenetic mechanism that regulates the onset and progression of many diseases, including spinal cord injury (SCI). To investigate the overall changes in m 1 A levels following SCI, we analyzed transcriptomic sequencing data from SCI samples and assigned m 1 A scores based on the levels of m 1 A regulatory factors. In this study, the m 1 A score is an inferred proxy calculated from the expression of m 1 A regulator genes (writers/erasers/readers). It does not directly measure RNA m 1 A modification levels. Our results show that the m 1 A score increased within the first day after SCI and then decreased, falling below baseline by day 3 and day 7. Further analysis revealed that microglia and neurons are the two cell types with the most significant changes in the m 1 A score. In microglia, m 1 A score decreased at all time points, whereas in neurons, m 1 A score increased at all time points. Additionally, through pseudotime analysis and function enrichment analysis, the m 1 A score may be associated with the phenotypic transition of microglia and neuronal energy metabolism, and this was further validated by conducting studies both in vivo and in vitro. In a word, our study unveils the characteristic changes of m 1 A at both the bulk and single-cell levels following SCI, and suggests potential links to neuronal function and supports the rationale for further studies exploring m 1 A-related regulators as therapeutic targets in SCI.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: